Radius Health Competitors and Similar CompaniesClear all

Radius Health's competitors and similar companies include CSL Behring, Genentech, UCB and Cipla.

	Radius Health Radius is a biopharmaceutical company developing new therapeutics for patients with osteoporosis and other serious endocrine-mediated diseases.	CSL Behring CSL Behring is a provider of life-saving medicines.	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.	Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
Founding Date	Founding Date 2003	Founding Date 1904	Founding Date 1976	Founding Date 1928	Founding Date 1935
Type	Type Public	Type Subsidiary	Type Subsidiary	Type Public	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Boston, US HQ Wayne, US	Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more	Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more
Employees	Employees 3834% decrease	Employees 7,5692% decrease	Employees 18,077	Employees 9,052	Employees 27,764
Valuation ($)	Valuation ($) 480.6 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 34.3 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $230m (FY, 2021)	Revenue (est.) $7.9b (FY, 2020)	Revenue (est.) N/A	Revenue (est.) €7.4b (FY, 2025)	Revenue (est.) ₹277.1b (FY, 2026)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods €1.4b (FY, 2025)	Cost of goods ₹95.5b (FY, 2026)
Gross profit	Gross profit N/A	Gross profit $4.5b (FY, 2020)	Gross profit N/A	Gross profit €7.2b (FY, 2025)	Gross profit ₹195b (FY, 2026)
Net income	Net income ($70.2m) (FY, 2021)	Net income N/A	Net income N/A	Net income €1.6b (FY, 2025)	Net income ₹38.7b (FY, 2026)
Operating ⚠
Countries	Countries N/A	Countries 100 (Dec, 2020)	Countries N/A	Countries 35 (FY, 2019)	Countries N/A